TAG:
lab operations
Lab Industry Attracting New Investment Dollars
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Professional investors with access to hundreds of millions of dollars of investment capital are closely scrutinizing the clinical laboratory industry. They are encouraged by the recent financial performance of public laboratory companies. For independent laboratory owners, th…
New CEO Takes Charge At Pathology Partners
By Robert Michel | From the Volume VII No. 8 – May 30, 2000 Issue
CEO SUMMARY: Pathology Partners, Inc. got a new President and CEO this month. The company is organized to build and operate independent regional histology and cytology laboratories in support of anatomic pathologists. Its business model is different than competing pathology companies and …
New Automation Tools Ready for Clinical Labs
By Robert Michel | From the Volume VII No. 7 – May 8, 2000 Issue
CEO SUMMARY: Evidence grows that workstation automation and modular automation can be cost-effective solutions in the clinical laboratory. But the newest generation of automation technology presents lab administrators with a new challenge. Financial analysis and workplace reengineering ar…
Honolulu Lab Pursuing Pacific Rim Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: With one laboratory already operating in Guam, Diagnostic Laboratory Services, Inc. (DLS) is poised to expand its services in the Pacific Rim area. Now a major competitor within Hawaii, DLS sees the island archipelagos of the Pacific Ocean as a natural extension of its existi…
Dynacare Buys LabSouth as Gateway into Alabama
By Robert Michel | From the Volume VII No. 1 – January 3, 2000 Issue
CEO SUMMARY: With the acquisition of ARL/LabSouth, based in Birmingham and Montgomery, Dynacare immediately becomes a major player in the Alabama marketplace. Several interesting aspects to the sale demonstrate that it is becoming increasingly difficult for independent commercial laborato…
Point-Of-Care Chemistry Ready To Transform Labs
By Robert Michel | From the Volume VI No. 16 – November 22, 1999 Issue
CEO SUMMARY: Following on the heels of our prediction about web-based test ordering/results reporting, here’s another equally revolutionary development. CARESIDE, Inc. is ready to launch a point-of-care instrument suite for routine, high-volume chemistry and hematology tests. Early peek…
Ten Management Myths Misled Clinical Laboratory Executives
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: We offer our second installment about the ten management myths which led the clinical laboratory industry astray during the 1980s and 1990s. Regretfully, clients responding to part one of this series tell us that these management myths remain alive and well—and continue to …
West Hills Hospital Lab Hits Outreach Home Run
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
CEO SUMMARY: Popular wisdom says that California’s managed care market is a financial disaster for clinical laboratories. Yet here’s an exciting story about a community hospital that launched a brand-new laboratory outreach program in 1997 and found solid success. During the last two …
Palo Alto Needle Reuse Episode Widens in Scope
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: As many as 15,000 people have been offered free blood testing because they may have been drawn by this phlebotomist since 1994. Regulatory action, private lawsuits, and media coverage are subjecting laboratories to unwelcome, even unwarranted, scrutiny. As the ramifications o…
Unilab Signs Agreement To Buy Bio-Cypher Labs
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
CEO SUMMARY: Unilab’s desire to purchase $60 million Bio-Cypher must be viewed against the impending acquisition by Quest Diagnostics of SmithKline Beecham Clinical Laboratories (SBCL). Whenever Quest takes control of SBCL’s lab operations, it automatically becomes a significant compe…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized